AVI-4126, a novel antisense compound; preclinical data presented recently support phase I/II trials April 12, 2000
Antitumor activity and pharmacokinetics of new taxoid TXD-258 discussed at ACS meeting April 12, 2000
Potent and selective oxindole cdk2 inhibitors display dual antitumor and chemoprotective effects April 11, 2000
RSS